-
proteins (NMRC)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development of selective and potent inhibitors of proteins has yielded remarkable results in disease
-
– Development of Lysine-Targeting, Cell-Active Covalent Inhibitors (CIs) with High Potency and Selectivity (MOE T2)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development
-
proteins (NMRC)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development of selective and potent inhibitors of proteins has yielded remarkable results in disease
-
Job Description Yale-NUS College is a highly selective liberal arts and science college in Singapore. Co-founded by Yale University and the National University of Singapore, the College is committed